Efficacy of occlusion therapy initiated in patients with untreated amblyopia beyond 7 years of age

Completed

• Conditions: lazy eye; Amblyopia; 10047518

• Registration Number: NL-OMON31331
• Lead Sponsor: Medisch Centrum Haaglanden, locatie Westeinde

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 22

Inclusion Criteria

All patients between seven and forty years of age, diagnosed with amblyopia associated with strabismus and/ or anisometropia (anisometropia <= >1.0 D of spherical equivalent or >1.50 D difference in astigmatism in any meridian) will be eligible for the study.

Exclusion Criteria

Previous treatment for amblyopia (includes occlusion, or pharmacological defocusing), previous optical correction of the amblyopic eye, ocular cause for reduced visual acuity, diminished acuity due to medication, brain damage, or trauma, neurological disorders, and eye muscle palsies.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcome parameter is visual acuity of the amblyopic eye five weeks<br /><br>after cessation of occlusion therapy. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcome parameters are cause of amblyopia, age at start occlusion<br /><br>therapy, fixation, visual acuity of the amblyopic eye at start and end of<br /><br>occlusion therapy, anisometropia, and aniseikonia. </p><br>